Tennessee’s Hepatitis C Rates Are Among the Highest in the Country
Tennessee consistently reports hepatitis C infection rates well above the national average. An estimated 100,000 people in the state are living with the virus — many without knowing it . That gap between actual infections and diagnosed cases is not a small detail. It shapes how the virus spreads, how long people go without treatment, and how serious the long-term consequences become.
Hepatitis C virus (HCV) is transmitted through blood-to-blood contact. It primarily affects the liver and, when left untreated over years or decades, can cause cirrhosis (scarring of the liver), liver failure, or liver cancer . The reason so many people remain undiagnosed is straightforward: the infection is often silent. Symptoms may not appear for 20 or 30 years after exposure, which means someone can carry the virus through most of their adult life without feeling sick.
Looking at the numbers in context — who is most affected, which regions carry the highest burden, and why — makes the case for testing clearer than any general recommendation can.
How Widespread Is Hepatitis C in Tennessee?
Nationally, the CDC estimates that approximately 2.4 million people in the United States are living with hepatitis C [source:4]. Tennessee’s share of that number is disproportionately high relative to its population. The state reports roughly 3,000 newly identified cases per year, though public health researchers widely acknowledge that reported figures undercount true prevalence because so many infections go undetected .
The reasons for Tennessee’s elevated rates are interconnected. The opioid epidemic, which hit the state hard throughout the 2000s and 2010s, drove a significant increase in injection drug use — the most common route of HCV transmission in the United States today [source:4]. Simultaneously, rural communities across the state face persistent barriers to healthcare access, which means fewer people get screened and fewer infections get caught early.
Globally, the World Health Organization estimates that 50 million people are living with chronic hepatitis C infection, with approximately 1 million new infections occurring each year . Tennessee’s situation reflects a broader pattern seen in regions where the opioid crisis intersected with limited healthcare infrastructure.
Which Populations Are Most Affected
Hepatitis C does not affect all groups equally. Two distinct demographic patterns have emerged over the past two decades, and understanding both matters for anyone trying to assess their own risk.
The Baby Boomer Generation
People born between 1945 and 1965 — often called the baby boomer generation — have historically carried a disproportionate share of HCV infections. Many were exposed before the virus was identified (HCV was discovered in 1989) and before blood supply screening became standard practice. The CDC has recommended one-time HCV testing for everyone in this birth cohort, regardless of known risk factors [source:4]. A significant portion of older Tennesseans living with HCV today were infected decades ago and may still be unaware.
Younger Adults and Injection Drug Use
Over the past decade, the fastest-growing group of new HCV infections has shifted toward adults under 40. This trend tracks directly with the rise of injection drug use tied to the opioid epidemic . Sharing needles, syringes, or other injection equipment — even once — can transmit the virus. In Tennessee, counties with higher rates of opioid prescribing and overdose deaths tend to show corresponding increases in hepatitis C diagnoses.
This demographic shift has changed how public health programs approach outreach. Testing programs that once focused almost exclusively on older adults now prioritize younger people, particularly those with a history of injection drug use or those currently using.
Geographic Patterns Across Tennessee
Hepatitis C rates vary considerably across the state, though no region is untouched. Rural Appalachian counties in East Tennessee have drawn particular attention in public health research, with studies pointing to the intersection of poverty, opioid use, and limited healthcare access as compounding factors [source:5]. When people lack a regular healthcare provider or cannot afford a clinic visit, they are less likely to be screened — and less likely to start treatment if diagnosed.
Urban centers tell a different story but not a better one. Nashville, Memphis, Knoxville, and Chattanooga all report elevated HCV rates, concentrated in neighborhoods affected by poverty, housing instability, and limited access to harm reduction services like needle exchange programs. High population density in these cities means the virus can spread more quickly, while social and economic marginalization can delay people from seeking care.
The common thread across both rural and urban areas is access. Where testing is hard to reach — geographically, financially, or because of stigma — infections accumulate undetected.
The Link Between Hepatitis C and the Opioid Crisis
Tennessee was among the states hardest hit by the opioid epidemic, and the connection to hepatitis C is direct. The CDC has documented a clear correlation between increases in injection drug use and rising HCV infection rates across multiple states [source:4]. When people share injection equipment, even a microscopic amount of blood can carry the virus from one person to another.
Harm reduction approaches — including syringe services programs, naloxone distribution, and access to medication-assisted treatment for opioid use disorder — have been shown to reduce HCV transmission rates. These are not fringe interventions. They are evidence-based public health tools that address transmission at its source.
For individuals currently using drugs, this context matters: HCV treatment is still possible and effective regardless of drug use status. Modern antiviral medications can clear the virus in most people within 8 to 12 weeks . A history of drug use does not disqualify anyone from treatment.
Why So Many Cases Go Undiagnosed
The gap between estimated prevalence and confirmed diagnoses is one of the most consequential features of the hepatitis C epidemic. Several factors drive it.
- No symptoms for years: Most people with chronic HCV infection feel fine for a long time. Without a reason to seek testing, many never do.
- Stigma around testing: Hepatitis C has historically been associated with drug use, which discourages some people from asking their doctor about it or seeking testing at a clinic.
- Cost and access barriers: Without insurance or a regular provider, getting tested can feel out of reach — even when testing itself may be available at no cost.
- Lack of awareness about risk: Many people do not know that a single exposure — a shared needle, an unscreened blood transfusion before 1992, or even shared personal items like razors — can transmit HCV.
The consequence of delayed diagnosis is serious. Chronic HCV infection causes progressive liver damage over time. By the time symptoms appear — fatigue, jaundice, abdominal pain — significant liver damage may already have occurred . Earlier diagnosis means earlier treatment, and earlier treatment means less damage.
Current Treatment: What the Data Shows
The treatment picture for hepatitis C has changed dramatically over the past decade. Direct-acting antiviral medications, introduced in the early 2010s, achieve cure rates above 95% in most patients . “Cure” here means sustained virologic response — the virus is undetectable in the blood 12 weeks after completing treatment and remains so. This is not management. It is elimination of the virus from the body.
Treatment typically involves taking one or two pills daily for 8 to 12 weeks, with minimal side effects compared to older interferon-based therapies . Most people complete treatment without significant disruption to daily life. Liver damage that has already occurred cannot be reversed, but stopping the virus prevents further progression — which is why earlier treatment consistently produces better outcomes.
The main barrier to treatment in Tennessee is not medical. It is access. The cost of these medications, without insurance coverage, can be prohibitive. That is the gap that no-cost programs are specifically designed to close.
Who Should Get Tested
Current CDC guidance recommends hepatitis C testing for all adults at least once, and more frequently for people with ongoing risk factors [source:4]. In practical terms, this means testing makes sense for anyone who:
- Was born between 1945 and 1965
- Has ever injected drugs, even once, at any point in their life
- Received a blood transfusion or organ transplant before July 1992
- Has been on long-term hemodialysis
- Has HIV
- Was born to a mother with hepatitis C
Testing is a simple blood draw. Results can often be returned quickly. A reactive (positive) screening result leads to a confirmatory test to determine whether the infection is current or was cleared on its own — roughly 15 to 25% of people clear the virus without treatment . If the infection is confirmed as current, the next step is an evaluation to determine the appropriate treatment course.
For anyone in Tennessee who has questions about their risk or wants to get screened, LifeLine Health’s Hepatitis C Testing and Treatment program provides confidential testing and treatment at no cost, with no insurance required. The program operates via telehealth, which means geography is not a barrier — whether you’re in Memphis, Knoxville, Chattanooga, or a rural county without a nearby clinic.
Getting Tested: What to Expect
One of the most common reasons people delay testing is not knowing what the process looks like. It is simpler than most people expect.
An initial appointment involves a brief conversation about your health history and risk factors, followed by a blood test. There is no judgment about how you may have been exposed. The purpose of the conversation is clinical — to understand your situation so care can be tailored appropriately. Results from the initial screening typically come back within a few days. If follow-up testing or treatment is needed, that process is explained clearly at each step.
Telehealth has made this more accessible for many Tennesseans. An appointment can happen from home, without transportation, without taking a full day off work, and without sitting in a waiting room. For people who have avoided healthcare settings because of past experiences with stigma or judgment, that difference matters.
If you want to learn more or get started, you can reach out directly — no referral needed, no insurance required.